Compositions for stimulation of mammalian innate immune resistance to pathogens
US10722573B2 · kind B2 · utility
0Cited by
98References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 18, 2016 |
| Grant date | Jul 28, 2020 |
| Priority date | — |
| Expiry date | Nov 18, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Embodiments of the invention are directed to methods of treating, inhibiting or attenuating a microbial infection in an individual who has or is at risk for developing such an infection, comprising the step of administering an effective amount of a StIR composition to the individual.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.